Navigation Links
Savient Pharmaceuticals Appoints Experienced Pharmaceutical Executive, David Veitch as President of Savient Europe
Date:1/13/2012

tablets, USP) CIII in the U.S. For more information, please visit the Company's website at www.savient.com.

FORWARD-LOOKING STATEMENTSAll statements other than statements of historical facts included in this press release are forward-looking statements that are subject to certain risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in such statements. These risks, trends and uncertainties are in some instances beyond our control. Words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," "will" and other similar expressions identify forward-looking statements, although not all forward-looking statements contain these identifying words. In particular, any statements regarding the safety and efficacy of KRYSTEXXA®, status of our KRYSTEXXA marketing efforts and additional plans related thereto, market demand and reimbursement for KRYSTEXXA, our view of the refractory chronic gout (RCG) market size, and our market expansion plans including our MAA filing before the EMA are forward-looking statements. These forward-looking statements involve substantial risks and uncertainties and are based on our assessment and interpretation of the currently available data and information, current expectations, assumptions, estimates and projections about our business and the biopharmaceutical and specialty pharmaceutical industries in which we operate. Important factors that may affect our ability to achieve the matters addressed in these forward-looking statements include, but are not limited to, our ability to commercialize KRYSTEXXA; our ability to retain the personnel whom we have hired and to hire the remaining personnel necessary to complete the build out of our commercial team; our reliance on third parties to manufacture KRYSTEXXA; the risk that the market for KRYSTEXXA is smaller than we have anticipated; competition fr
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA®
2. Savient Pharmaceuticals to Present at the Noble Financial Capital Markets Eighth Annual Equity Conference
3. Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA® and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting
4. Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results
5. Savient Pharmaceuticals to Hold Third Quarter 2011 Financial Results Conference Call on Thursday, November 3, 2011
6. Savient Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
7. Savient Pharmaceuticals Names Kenneth J. Zuerblis Chief Financial Officer
8. Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients
9. Savient Pharmaceuticals to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference
10. Savient Pharmaceuticals Reports Second Quarter 2011 Financial Results
11. Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015  Rigrodsky & Long, P.A.: ... Inc. (NASDAQ GM: AERI )? , Did you purchase ... , Did you lose money in your investment in Aerie ... Rigrodsky & Long, P.A. , including ... announces that a complaint has been filed in the United States ...
(Date:5/6/2015)... South Africa , May 6, 2015 ... than HIV/AIDS, malaria and tuberculosis combined[1]. Approximately 40 percent of ... cured with the right treatment[3]. Together with Elekta, ministries of ... build up their radiation therapy infrastructures and save lives. ... would benefit from radiation therapy[4] during the course of their ...
(Date:5/6/2015)... Markets ( http://www.researchandmarkets.com/research/jskhnb/energy_based ) has announced the addition ... Business Report" report to their offering. The ... Canada , Japan , ... of World. Annual estimates and forecasts are provided for the ... provided for these markets. The global market is ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 2SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 3Elekta to bring cancer treatment to millions in Africa 2Elekta to bring cancer treatment to millions in Africa 3Elekta to bring cancer treatment to millions in Africa 4Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 3
(Date:5/6/2015)... Chesapeake Regional Medical Center is the ... acquire Intuitive Surgical, Inc.’s latest model of the ... enhanced surgical technique capabilities, which can be used ... spectrum of specialties. Its advancements allow patients less ... times. , “As the only independent, community-based hospital ...
(Date:5/6/2015)... May 06, 2015 The Beryl Institute ... of Patient Experience Journal (PXJ), an international, open ... around understanding and improving patient experience. The second volume ... experience conversation globally, helps align the voices engaged and ... , Published in association with The Beryl Institute, Volume ...
(Date:5/6/2015)... 06, 2015 Is Colorado’s legal cannabis ... month the Centennial State will mark the 18-month milestone ... to adults. And while Colorado’s legal marijuana industry has ... time, it’s also facing some new challenges. , For ... facing shortages, especially in the wake of last month’s ...
(Date:5/6/2015)... vcfo, a specialized consulting firm that provides ... to optimize business performance and productivity, announced the additions ... Scheaffer. Both Lynch and Scheaffer have more than 25 ... “We are delighted to add Jack and Mike to ... background in financial management and leadership, Mike and Jack ...
(Date:5/6/2015)... Anitoa Systems, (“Anitoa”), a Palo Alto startup ... China, has successfully demonstrated a handheld real time quantitative-polymerase-chain-reaction ... Anitoa’s handheld qPCR is shown to be capable of ... hepatitis B, C, and E. Coli. This qPCR system ... and over 9 orders of magnitude dynamic range. ...
Breaking Medicine News(10 mins):Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 3Health News:vcfo Adds Two Senior Executives to Growing Team 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 3
... is so much alike the code of humans, almost a ... And yet, // there are glaring differences, despite the 98% ... not a different set of genes that caused the difference, ... According to a latest theory on evolution, even small alterations ...
... many are not aware of the Medicare part D program’s guidelines. ... Roxbury Presbyterian Church was a great relief for them. ... the bus, which has been traversing New England cities and towns ... , The deadline to sign up for new prescription drug coverage ...
... Women with disproportionate or uneven breasts have a greater likelihood ... record any alterations or changes in the breast, the study ... conducted a study where mammograms of 252 women who developed ... healthy women. It was observed that, though breast cancer ...
... psychiatrist Dr Charles Reynolds at the University of Pittsburgh which ... , The study’s main aim was to analyze the ... people. It is one of the longest studies ever ... antidepressants for longer periods, perhaps even for life, in patients ...
... nominated to run the U.S. Food and Drug Administration, ... pressure while scientific decisions were being made//. He further ... medical endeavors, the appropriateness should also be taken into ... the FDA and Director of National Cancer Institute, would ...
... years old and two adults were placed under quarantine in ... part of Maharashtra. ,Tina Nanavade from Rawer taluka, ... was admitted to Nhavi Hospital on Sunday afternoon. Tami flu ... a possible bird-flu. ,Sarla More from Jamner, a ...
Cached Medicine News:Health News:Drugs Are Effective In Treating Depression and Preventing Recurrence 2Health News:FDA Nominee Says That He Is Not Influenced By Politics 2
... volume laboratories, as well as specialty labs, ... simplicity and flexibility needed to respond to ... Elecsys 1010 system enables operators to handle ... testing without sacrificing ease of operation or ...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t...
... System provides high-performance detection technologies to ... and therapeutic drugs. It also delivers ... that allow the laboratory to streamline ... This high-productivity design enables numerous functions ...
The Embla 384 cell washer is a top-loading, robotic-compatible microplate washer for high throughput screening. It is designed specifically for cell-based assays, which require a gentler wash, but ca...
Medicine Products: